Male infertility medicine may be a more popular option for men in the United States than female infertility medicine, according to a new study.
Male hormone therapy and pax man medicine are both approved by the Food and Drug Administration for treatment of men’s androgen deficiency.
The study by researchers at the University of Southern California looked at the effectiveness of male hormone therapy on the treatment of prostate cancer.
In the study, they analyzed data from more than 1,000 men with prostate cancer who had undergone male hormone treatment for a total of 1,726.
The results were published in the journal Clinical Oncology.
The men were randomly assigned to receive either pax-male-medicine, a combination of male hormones and steroids that contains testosterone and male growth hormone.
Or, they were given pax medica, a generic version of pax that contains only male hormones.
Pax-man-medics use male hormones to help men’s fertility.
Male hormones are a naturally occurring hormone in men.
In order to produce the male hormones, the body needs to break down its own male sex hormone testosterone.
That’s why male hormone treatments often work in men with low testosterone levels.
Pavlova said the findings are promising, but the study doesn’t show that pax is a safe and effective alternative to the testosterone treatment that many men in his study had undergone.
He said that pox pills can have side effects and that some men may not be able to take the pill correctly.
The FDA is still reviewing the study and is expected to make a decision on whether to approve pax medicine in the near future, said Pavlova.
For now, the FDA is considering the results of the study in a separate study.
The research was supported by the National Institute on Aging and the National Cancer Institute.
More stories from The Wall St. Journal: